The National Institutes of Health said Thursday that Dr. Eliezer Masliah, a prominent Alzheimer’s and Parkinson’s disease researcher, falsified or fabricated images published in two papers, which it ...

Legal counsel for the 83-year-old CEO of Herring Networks seek to block his deposition in Dominion Voting's ...

As caregivers tend to a loved one dealing with Alzheimer’s disease, their well being needs to be supported. That helps the caregivers not only emotionally but also answers questions during the slow ...

More than 350 area residents participated in this year’s Walk to End Alzheimer’s – Rowan-Cabarrus in the fight to end ...

New research shows that older adults vulnerable to financial scams may have brain changes linked to a higher risk of ...

The Shark Tank investor kept her mom's diagnosis a secret until she could evaluate her own risk of Alzheimer's. She's finally ...

The Securities and Exchange Commission today announced Cassava Sciences, Inc., its founder and former CEO, Remi Barbier, and its former Senior Vice President of Neuroscience, Dr. Lindsay Burns, will ...

Cassava Sciences and two former executives will pay more than $40 million to settle charges related to misleading statements made about a clinical trial for the company's purported therapeutic ...

Heart disease is the No. 1 killer of Americans. However, having high LDL-C cholesterol levels doesn’t always lead to heart ...

University of Iowa Hospital's and Clinics is seeking participants for a study in which they are testing a new drug aimed at helping those with Alzheimer's.

A report published Wednesday in The BMJ questioned the safety and effectiveness of the Alzheimer’s disease drug Kisunla ...

Driving the Amyloid Cascade? A microglial subtype, Mic.12, promotes plaque deposition, while another, Mic.13, promotes tangles. An astrocyte subtype, Ast.10, contributes to cognitive decline, as well ...